“cannabis”的搜索结果，显示 151-160 项，共有 2049 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...

2. 血液科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to correlate gut microbiome with specific cancer diagnoses and the ...

3. 泌尿科- 临床试验- 妙佑医疗国际

   Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Does the treatment show effectiveness on advanced sarcoma. Participants will: Take drug [Ac225]RTX-2358 once every 8 weeks (4 cycle target; 6 cycle maximum) ...